Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Acorda Therapeutics News

    0,55 $ +5,77% +0,03 $
    In : 0,5136 € | 24.04.24 21:52:23 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EJA8
    ISIN: US00484M7002
    US-Symbol: ACORQ
    Typ: Aktie

    Acorda Therapeutics News

    17.10.22 - PR Newswire
    Thinking about buying stock in Federated National, Acorda Therapeutics, Nio, Avenue Therapeutics, or Visa?
    Thinking about buying stock in Federated National, Acorda Therapeutics, Nio, Avenue Therapeutics, or Visa? PR Newswire
    10.10.22 - PR Newswire
    Thinking about buying stock in Exela Technologies, Acorda Therapeutics, NovaBay Pharmaceuticals, Meta Materials, or Faraday Future Intelligent Electric?
    Thinking about buying stock in Exela Technologies, Acorda Therapeutics, NovaBay Pharmaceuticals, Meta Materials, or Faraday Future Intelligent Electric? PR Newswire
    23.07.21 - PR Newswire
    Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences?
    Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences? PR Newswire
    17.06.21 - PR Newswire
    Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals?
    Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals? PR Newswire
    20.10.20 - PR Newswire
    Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices?
    Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices? PR Newswire
    06.05.20 - PR Newswire
    DexCom & Domino's Pizza Set to Join S&P 500; Salesforce.com to Join S&P 100; STORE Capital to Join S&P MidCap 400; Capri Holdings to Join S&P SmallCap 600
    DexCom & Domino's Pizza Set to Join S&P 500; Salesforce.com to Join S&P 100; STORE Capital to Join S&P MidCap 400; Capri Holdings to Join S&P SmallCap 600 PR Newswire
    23.05.19 - PR Newswire
    Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE
    Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, ...
    22.12.17 - PR Newswire
    EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Acorda Therapeutics, Inc. - ACOR
    EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Acorda Therapeutics, Inc. - ACOR PR Newswire
    16.12.17 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ACOR
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ...
    14.12.17 - PR Newswire
    Shareholder Class Action Filed Against Acorda Therapeutics, Inc. - ACOR
    Shareholder Class Action Filed Against Acorda Therapeutics, Inc. - ACOR PR Newswire
    12.12.17 - PR Newswire
    ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acorda Therapeutics, Inc. To Contact The Firm
    ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acorda Therapeutics, Inc. To Contact The ...
    04.12.17 - PR Newswire
    ACT NOW: Monteverde & Associates PC Announces An Investigation of Acorda Therapeutics, Inc. - ACOR
    ACT NOW: Monteverde & Associates PC Announces An Investigation of Acorda Therapeutics, Inc. - ACOR PR Newswire
    28.11.17 - PR Newswire
    Johnson Fistel, Announces Investigations of INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc.; Investors Encouraged to Contact Firm
    Johnson Fistel, Announces Investigations of INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc.; Investors Encouraged to Contact Firm PR Newswire
    20.11.17 - PR Newswire
    SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline: January 17, 2018
    SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline: January 17, ...
    16.11.17 - PR Newswire
    ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm
    ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm PR ...
    15.11.17 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR PR Newswire
    15.11.17 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR PR Newswire
    15.11.17 - PR Newswire
    Kaplan Fox Announces Investigation of Acorda Therapeutics, Inc.
    Kaplan Fox Announces Investigation of Acorda Therapeutics, Inc. PR Newswire
    15.11.17 - PR Newswire
    INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acorda Therapeutics, Inc. (ACOR)
    INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acorda Therapeutics, Inc. (ACOR) PR Newswire
    15.11.17 - PR Newswire
    Thinking about buying Acorda Therapeutics, JA Solar, Ultragenyx Pharmaceuticals, Square Inc. or Target?
    Thinking about buying Acorda Therapeutics, JA Solar, Ultragenyx Pharmaceuticals, Square Inc. or Target? PR Newswire

    Newssuche

    Videos

    newspaper
    24.04.24
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »